Iris Dorbian
Miraki Innovation has launched a $175 million medical technology breakthrough fund. This will be the third fund started and managed by Christopher Velis, founder of Miraki Innovation and co-founder of Auris Health.
Denver-based Geospiza, a startup that enables emergency managers, first responders, and program managers to quickly make data-driven decisions that improve results, ROI and save lives, has raised $1 million in funding. The backers included Techstars, GAN Ventures, Next Wave Ventures, Chloe Capital, Alumni Ventures Group and Kokopelli Ventures.
Denver-based Geospiza, a startup that enables emergency managers, first responders, and program managers to quickly make data-driven decisions that improve results, ROI and save lives, has raised $1 million in funding. The backers included Techstars, GAN Ventures, Next Wave Ventures, Chloe Capital, Alumni Ventures Group and Kokopelli Ventures.
Tools4Patient SA, a Belgian developer of tools to optimize and accelerate drug development programs, has raised $4.5 million in Series B financing. The investors included Innovation Fund, Sambrinvestm, Jean-Pierre Delwart, former CEO of Eurogentec and Jean Stephenne, former president of GlaxoSmithKline Biologicals.
Tools4Patient SA, a Belgian developer of tools to optimize and accelerate drug development programs, has raised $4.5 million in Series B financing. The investors included Innovation Fund, Sambrinvestm, Jean-Pierre Delwart, former CEO of Eurogentec and Jean Stephenne, former president of GlaxoSmithKline Biologicals.
San Francisco-based Wheelwell Inc, a social-commerce company for the automotive market, has raised $3 million in financing. James Currier of NFX Capital and Hans Tung of GGV Capital led the round.
San Francisco-based Wheelwell Inc, a social-commerce company for the automotive market, has raised $3 million in financing. James Currier of NFX Capital and Hans Tung of GGV Capital led the round.
San Francisco and Scottsdale-based Boomtown, which helps organizations that sell, activate and support business technology products, has raised $12 million in Series B funding. Telstra Ventures led the round with participation from Capital One Growth Ventures, Nyca Partners, Commerce Ventures, Spider Capital and NHN Ventures.
San Francisco and Scottsdale-based Boomtown, which helps organizations that sell, activate and support business technology products, has raised $12 million in Series B funding. Telstra Ventures led the round with participation from Capital One Growth Ventures, Nyca Partners, Commerce Ventures, Spider Capital and NHN Ventures.
New York City-based Prevail Therapeutics Inc, a gene therapy company, has promoted Dr. Yong Dai to chief technology officer. Also, the company has named Tim Adams to its board of directors as audit committee chair while Dr. Francois Nader, a member of the board, will expand his role as non-executive chairman. Prevail's backers include OrbiMed, Pontifax Fund, RA Capital Management, EcoR1 Capital, Omega Funds, BVF Partners LP, Boxer Capital LLC, Adage Capital Management LP and Alexandria Venture Investments.